← Product Code [KAM](/submissions/SU/subpart-e%E2%80%94surgical-devices/KAM) · K110687 # RELIEVA STRATUS PRO MICROFLOW SPACER (FRONTAL) (K110687) _Acclarent, Inc. · KAM · Oct 7, 2011 · General, Plastic Surgery · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/KAM/K110687 ## Device Facts - **Applicant:** Acclarent, Inc. - **Product Code:** [KAM](/submissions/SU/subpart-e%E2%80%94surgical-devices/KAM.md) - **Decision Date:** Oct 7, 2011 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 878.4800 - **Device Class:** Class 1 - **Review Panel:** General, Plastic Surgery - **Attributes:** Therapeutic ## Intended Use The MicroFlow Spacer (Frontal) is indicated for use as a postoperative spacer to maintain an opening to the frontal sinuses within the first 14 days following surgery. The MicroFlow Spacer also helps to prevent obstruction. ## Device Story Relieva Stratus Pro MicroFlow Spacer (Frontal) is a postoperative sinus spacer; implanted into frontal sinuses to maintain patency for up to 14 days post-surgery; utilizes self-retention mechanism to maintain position; manually removed by physician during office follow-up visit; helps prevent obstruction; device is non-pyrogenic; sterile. ## Clinical Evidence Bench testing only. Performance testing confirmed device met all acceptance criteria. Sterilization validated per AAMI/ANSI/ISO 11135-1:2007; non-pyrogenic per ANSI/AAMI ST72:2002; ethylene oxide residuals meet ISO 10993-7:2008; shelf life established at 13 months per ASTM F1980-07; package integrity validated per ASTM F88-07A, ISTA 2A-08, and ASTM F2096-04. ## Technological Characteristics Implantable frontal sinus spacer with self-retention mechanism. Sterilized via ethylene oxide (AAMI/ANSI/ISO 11135-1:2007). Shelf life 13 months (ASTM F1980-07). Package integrity testing per ASTM F88-07A, ISTA 2A-08, and ASTM F2096-04. Non-pyrogenic (ANSI/AAMI ST72:2002). ## Regulatory Identification A manual surgical instrument for general use is a nonpowered, hand-held, or hand manipulated device, either reusable or disposable, intended to be used in various general surgical procedures. The device includes the applicator, clip applier, biopsy brush, manual dermabrasion brush, scrub brush, cannula, ligature carrier, chisel, clamp, contractor, curette, cutter, dissector, elevator, skin graft expander, file, forceps, gouge, instrument guide, needle guide, hammer, hemostat, amputation hook, ligature passing and knot-tying instrument, knife, mallet, disposable or reusable aspiration and injection needle, disposable or reusable suturing needle, osteotome, pliers, rasp, retainer, retractor, saw, scalpel blade, scalpel handle, one-piece scalpel, snare, spatula, stapler, disposable or reusable stripper, stylet, suturing apparatus for the stomach and intestine, measuring tape, and calipers. A surgical instrument that has specialized uses in a specific medical specialty is classified in separate regulations in parts 868 through 892 of this chapter. ## Predicate Devices - Relieva Stratus MicroFlow Spacer ([K093594](/device/K093594.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ KII0687 OCT - 7 2011 ## 8. 510(K) SUMMARY | Sponsor/Submitter: | Acclarent, Inc.
1525-B O'Brien Drive
Menlo Park, California 94025 | |-----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Contact Person: | Dean Knight
Senior Manager, Regulatory Affairs
Phone: (650) 687-4807
Fax: (650) 687-4449 | | Date of Submission: | March 9, 2011 | | Device Trade Name: | Relieva Stratus Pro MicroFlow Spacer (Frontal) | | Common Name: | Sinus cannula | | Device Classification: | Class I | | Regulation Number: | 21 CFR 878.4800 | | Classification Name: | Manual surgical instrument for general use | | Product Code: | KAM | | Predicate Device: | Relieva Stratus MicroFlow Spacer (K093594) | | Device Description: | The Relieva Stratus Pro MicroFlow Spacer (Frontal) is a device
that maintains an opening at the target sinus for up to 14 days
postoperatively. The device can be manually removed during an
office follow-up visit. | | Indications for Use: | The MicroFlow Spacer is indicated for use as a postoperative spacer
to maintain an opening to the frontal sinuses within the first 14 days
following surgery. The MicroFlow Spacer also helps to prevent
obstruction. | | Technological
Characteristics: | The Relieva Stratus Pro MicroFlow Spacer (Frontal) is designed to
be implanted into the frontal sinuses and to maintain its position by
a self-retention mechanism.
The safety and effectiveness of injecting solutions other than saline
solution in the catheter have not been established. | | Performance Data: | The Relieva Stratus Pro MicroFlow Spacer (Frontal) met all
performance acceptance criteria.
The sterilization process is validated per AAMI/ANSI/ISO 11135-
1: 2007. The device meets the requirements for a sterility
assurance level of 10-6.
The device is non-pyrogenic per ANSI/AAMI ST72:2002. | {1}------------------------------------------------ requirements. Post-sterilization ethylene oxide residuals were tested and meet ISO 10993-7:2008 requirements. Shelf life was established at 13 months per ASTM F1980-07 requirements. Package integrity at the end of the shelf life was established per ASTM F88-07A, ISTA 2A-08, and ASTM F2096-04 requirements. Summary of Substantial Equivalence: The Relieva Stratus Pro MicroFlow Spacer (Frontal) is substantially equivalent to the predicate device as confirmed through relevant performance tests. {2}------------------------------------------------ Public Health Service Food and Drug Administration 1 0903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Acclarent, Inc. c/o Mr. Dean Knight Senior Manager, Regulatory Affairs 1525-B O'Brien Drive Menlo Park, CA 94025 OCT - 7 200 Re: K110687 Trade/Device Name: Relieva Stratus Pro MicroFlow Spacer (Frontal) Regulation Number: 21 CFR 878.4800 Regulation Name: Manual surgical instrument for general use Regulatory Class: Class I Product Code: KAM Dated: September 7, 2011 Received: September 9, 2011 Dear Mr. Knight: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act (Act) that do trequire approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misting and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 - Mr. Dean Knight Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administred by other Federal agencies. You must comply with all the Act 's requirements including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the election in radiation control provisions (Section (21 CFR Part 820); and if applicable, the elec radiation control provisions (21 CFR Part 820); and If applicable, the elections 531-542 of the Act.); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/ContemOff. - (CDPMCF 1 go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.html for the Center for Devices and Radiological Health s (CDRHCDRHCesuum 115809.htm for note the regulation entitled "Michaeline base is a level se office of Compliance. Also, pleas note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding of reference to premated notification" (21CFR Part 807.97). For questions regarding of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International only on tesponsibilities under the Act from the (800) 638-2041 or (101) 796-7100 or at its June Assistance at its toll-free num (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. https://www.fda.gov/MedicalDevices/ResourceforYou/Industry/default.htm. Sincerely yours, Malvina R. Fudala, M.D. Malvina B. Eydelman, Director Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ K110687 Special 510(k) Premarket Notification Acclarent, Inc. March 2011 Page 13 of 50 ## 7. STATEMENT OF INDICATIONS FOR USE Indications for Use 510(k) Number (if known): KIID687 Device Name: Relieva Stratus Pro MicroFlow Spacer (Frontal) __________________________________________________________________________________________________________________ Indications for Use: The MicroFlow Spacer (Frontal) is indicated for use as a postoperative spacer to maintain an opening to the frontal sinuses within the first 14 days following surgery. The MicroFlow Spacer also helps to prevent obstruction. Prescription Use V (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Daniel C. Clapp (Division Sign-Off) Division of Ophthalmic, Neurological and Ear, Nose and Throat Devices 510(k) Number K110687 Page 1 of 1 --- **Source:** [https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/KAM/K110687](https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/KAM/K110687) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com